BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9916069)

  • 1. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
    Jiang C; Magee DM; Quitugua TN; Cox RA
    Infect Immun; 1999 Feb; 67(2):630-5. PubMed ID: 9916069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
    Jiang C; Magee DM; Ivey FD; Cox RA
    Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against infection with Coccidioides immitis in mice.
    Peng T; Shubitz L; Simons J; Perrill R; Orsborn KI; Galgiani JN
    Infect Immun; 2002 Jul; 70(7):3330-5. PubMed ID: 12065470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.
    Jiang C; Magee DM; Cox RA
    Infect Immun; 1999 Nov; 67(11):5848-53. PubMed ID: 10531239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.
    Abuodeh RO; Shubitz LF; Siegel E; Snyder S; Peng T; Orsborn KI; Brummer E; Stevens DA; Galgiani JN
    Infect Immun; 1999 Jun; 67(6):2935-40. PubMed ID: 10338502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
    Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
    Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
    Herr RA; Hung CY; Cole GT
    Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen.
    Lecara G; Cox RA; Simpson RB
    Infect Immun; 1983 Jan; 39(1):473-5. PubMed ID: 6822433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.
    Shubitz L; Peng T; Perrill R; Simons J; Orsborn K; Galgiani JN
    Infect Immun; 2002 Jun; 70(6):3287-9. PubMed ID: 12011027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA.
    Zhu Y; Yang C; Magee DM; Cox RA
    Infect Immun; 1996 Jul; 64(7):2695-9. PubMed ID: 8698497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholera vaccine candidate 638: intranasal immunogenicity and expression of a foreign antigen from the pulmonary pathogen Coccidioides immitis.
    Silva AJ; Mohan A; Benitez JA
    Vaccine; 2003 Dec; 21(32):4715-21. PubMed ID: 14585681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coccidioidomycosis: host response and vaccine development.
    Cox RA; Magee DM
    Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maize-Produced Ag2 as a Subunit Vaccine for Valley Fever.
    Hayden CA; Hung CY; Zhang H; Negron A; Esquerra R; Ostroff G; Abraham A; Lopez AG; Gonzales JE; Howard JA
    J Infect Dis; 2019 Jul; 220(4):615-623. PubMed ID: 31184702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice.
    Kirkland TN; Finley F; Orsborn KI; Galgiani JN
    Infect Immun; 1998 Aug; 66(8):3519-22. PubMed ID: 9673228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-based immunization induces Coccidioides Ag2/PRA-specific immune response.
    Awasthi S; Vilekar P; Conkleton A; Rahman N
    Vaccine; 2019 Mar; 37(12):1685-1691. PubMed ID: 30795939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a protective antigen of Coccidioides immitis by expression library immunization.
    Ivey FD; Magee DM; Woitaske MD; Johnston SA; Cox RA
    Vaccine; 2003 Oct; 21(27-30):4359-67. PubMed ID: 14505918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
    Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
    Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a 48-kilodalton recombinant T-cell-reactive protein of Coccidioides immitis.
    Kirkland TN; Thomas PW; Finley F; Cole GT
    Infect Immun; 1998 Feb; 66(2):424-31. PubMed ID: 9453590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae.
    Silva AJ; Benitez JA
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):393-8. PubMed ID: 15708313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.
    Delgado N; Xue J; Yu JJ; Hung CY; Cole GT
    Infect Immun; 2003 Jun; 71(6):3010-9. PubMed ID: 12761077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.